Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Present at the Jones Healthcare and Technology Innovation Conference

Tuesday, April 1, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. (Nasdaq: CLNN) has announced its participation in the upcoming Jones Healthcare and Technology Innovation Conference, where the management will give a presentation and host one-on-one investor meetings. The event aims to promote Clene's innovative approach to treating neurodegenerative diseases, such as ALS and MS. The presentation will take place in Las Vegas, NV, and a webcast will be available on Clene's website for interested parties.
Price reaction · baseline $3.08 (2025-03-31 close) · hit after-hours · clean, no other CLNN news in the window
day 0 close · peak
-16.2%
day 1
-2.6%
day 3
-12.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is participating in a high-profile industry conference.
  • The company is focused on neurodegenerative diseases, addressing significant unmet medical needs.
  • The presentation may enhance Clene's visibility among investors and industry stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the Jones Healthcare and Technology Innovation Conference and host 1x1 investor meetings.
Time of Presentation: 11:30 am PT
Location: Las Vegas, NV, Venetian Resort
Format: Presentation
1x1 Meetings: Please contact your Jones representative.
A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link

Frequently Asked Questions

What is Clene Inc. focused on?

Clene Inc. specializes in treating neurodegenerative diseases like ALS and MS.

When will Clene present at the conference?

Clene's presentation is scheduled for 11:30 am PT on April 1, 2025.

Where is the Jones Conference held?

The Jones Conference takes place at the Venetian Resort in Las Vegas, NV.

How can investors meet with Clene's management?

Investors can arrange 1x1 meetings by contacting their Jones representative.

Will the presentation be available online?

Yes, a webcast of the presentation will be accessible on Clene's website.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. neurodegenerative diseases ALS multiple sclerosis Investor meetings
Last updated: Apr 1, 2025

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →